Based on cholinergic hypothesis, AChE inhibitors are the most prescribed drugs against the disease, as patients with AD have an apparent deficit in acetylcholine (ACh) and possess multifactorial and complex pathophysiology. This evidence concerns the gene ACHE and Alzheimer disease.